Pharmaceutically acceptable salt of a substituted pyridin-3-yl-imidazolidinone compound
PK201200408A0Undetermined Publication Date: 2012-07-25NOVARTIS AG
Patent Information
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- NOVARTIS AG
- Filing Date
- 2012-06-25
- Publication Date
- 2012-07-25
Abstract
The present invention provides a pharmaceutically acceptable salt of a compound of Formula (lb) where R^°, R51, R52, R53, R64, p, and n are as defined herein. The pharmaceutically acceptable salt of the compound of the present invention has been found to be useful as 17αhydroxylase / Οτ 7 2o-lyase inhibitor.
Need to check novelty before this filing date? Find Prior Art